During the past decade, Grand Traverse Allergy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Grand Traverse Allergy" are "Hereditary Angioedema" (3 trials) and "Chronic Sinusitis" (1 trials). Many other conditions were trialed in "Grand Traverse Allergy" in a lesser frequency.

Most popular intervention types in "Grand Traverse Allergy" are "Biological" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "C1 esterase inhibitor [human] (C1INH-nf)" (3 trials), "Placebo (saline)" (1 trials) and "SinuNase" (1 trials). Other intervention names were less common.

The vast majority of trials in "Grand Traverse Allergy" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Grand Traverse Allergy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Grand Traverse Allergy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Grand Traverse Allergy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Grand Traverse Allergy has several departments that took part in Clinical trials: "Traverse Heart and Vascular" - 2 trials